As of 2025-09-13, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is 167.12 USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.78 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is 354.4%.
The range of the Relative Valuation is 131.23 - 210.58 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 18.8x | 15.6x |
| Forward P/E multiples | 13.6x - 20.5x | 16.5x |
| Fair Price | 131.23 - 210.58 | 167.12 |
| Upside | 256.8% - 472.5% | 354.4% |
| Date | P/E |
| 2025-09-10 | 3.19 |
| 2025-09-09 | 3.23 |
| 2025-09-08 | 3.25 |
| 2025-09-05 | 3.22 |
| 2025-09-04 | 3.23 |
| 2025-09-03 | 3.63 |
| 2025-09-02 | 3.51 |
| 2025-08-29 | 3.37 |
| 2025-08-28 | 3.41 |
| 2025-08-27 | 3.51 |
| 2025-08-26 | 3.44 |
| 2025-08-25 | 3.33 |
| 2025-08-22 | 3.47 |
| 2025-08-21 | 3.41 |
| 2025-08-20 | 3.29 |
| 2025-08-19 | 3.24 |
| 2025-08-18 | 3.35 |
| 2025-08-15 | 3.31 |
| 2025-08-14 | 3.28 |
| 2025-08-13 | 3.27 |
| 2025-08-12 | 3.16 |
| 2025-08-11 | 3.14 |
| 2025-08-08 | 3.20 |
| 2025-08-07 | 3.31 |
| 2025-08-06 | 3.37 |
| 2025-08-05 | 3.24 |
| 2025-08-04 | 3.23 |
| 2025-08-01 | 3.13 |
| 2025-07-31 | 3.33 |
| 2025-07-30 | 3.36 |
| 2025-07-29 | 3.37 |
| 2025-07-28 | 3.32 |
| 2025-07-25 | 3.57 |
| 2025-07-24 | 3.54 |
| 2025-07-23 | 3.62 |
| 2025-07-22 | 3.54 |
| 2025-07-21 | 3.57 |
| 2025-07-18 | 3.57 |
| 2025-07-17 | 3.61 |
| 2025-07-16 | 3.57 |
| 2025-07-15 | 3.50 |
| 2025-07-14 | 3.51 |
| 2025-07-11 | 3.49 |
| 2025-07-10 | 3.53 |
| 2025-07-09 | 3.49 |
| 2025-07-08 | 3.24 |
| 2025-07-07 | 3.15 |
| 2025-07-03 | 3.22 |
| 2025-07-02 | 3.16 |
| 2025-07-01 | 3.07 |